Listing 1 - 2 of 2 |
Sort by
|
Choose an application
Osteonecrosis of the jaws is a well-known side-effect of antiresorptive therapy that predominantly occurs in patients suffering from malignant diseases and receiving intravenous administrations of nitrogen-containing bisphosphonates or subcutaneous administrations of denosumab, a monoclonal antibody. Less frequently it may also be observed in patients with osteoporosis who are being treated with these antiresorptive drugs. This textbook provides detailed, up-to-date information on all aspects of medication-related osteonecrosis of the jaws, including clinical features, pathogenesis, treatment options, and preventive measures. It also explains safe prevention and treatment strategies for patients receiving antiresorptive drugs who require extractions, implant insertions, and other dento-alveolar surgeries. This book will be of major interest for medical and dental students, dentists, and oral and maxillofacial surgeons as well as osteologists and oncologists.
Medicine & Public Health. --- Oral and Maxillofacial Surgery. --- Dentistry. --- Medicine. --- Surgery. --- Médecine --- Dentisterie --- Chirurgie --- Dentistry --- Health & Biological Sciences --- Oral Surgery --- Jaws --- Osteoporosis --- Necrosis. --- Chemotherapy --- Complications. --- Phossy jaw --- Oral surgery. --- Maxillofacial surgery. --- Bones --- Vitamin D deficiency --- Diseases --- Surgery, Primitive --- Medicine --- Dental surgery --- Odontology --- Surgery, Dental --- Oral medicine --- Teeth --- Oral surgery --- Surgery, Oral --- Oral surgeons
Choose an application
Bisphosphonates are commonly prescribed to inhibit bone loss in patients with osteoporosis, as well as osteopenia, cancer, and Paget's disease of the bone. Recently, scientific literature has addressed a possible relationship between bisphosphonates and osteonecrosis of the jaw (ONJ). It is important to note that though the risks for developing ONJ are much higher for cancer patients on intravenous bisphosphonate therapy (used to reduce bone pain), the occurrence of ONJ also in patients treated with oral BF for osteoporosis has been also highlighted, though rarely. On the basis of the large use of BF, of their pharmacokinetics, of the systemic and local risk factors, physicians prescribing them and dental surgeons should be well informed on the various aspects of the problem. Aim of this volume is to offer an update on the current status of prevention, and on the current conservative and surgical treatments. The multidisciplinary approach will be very much appreciated by GP’s, the different specialists using bisphosphonates and by dental surgeons.
Bones -- Necrosis. --- Diphosphonates -- Physiological effect. --- Jaws -- Necrosis. --- Temporomandibular joint --- Organophosphorus Compounds --- Organic Chemicals --- Chemicals and Drugs --- Diphosphonates --- Medicine --- Dentistry --- Health & Biological Sciences --- Diseases by Body Region --- Oral Surgery --- TMJ Diseases --- Diseases --- Jaws --- Bones --- Necrosis. --- Physiological effect. --- Biphosphonates --- Bisphosphonates --- Osteonecrosis --- Phossy jaw --- Dentistry. --- Pharmacy. --- Medicine. --- General practice (Medicine). --- Radiology. --- Hematology. --- Oral surgery. --- Maxillofacial surgery. --- Medicine & Public Health. --- Oral and Maxillofacial Surgery. --- General Practice / Family Medicine. --- Imaging / Radiology. --- Phosphonates --- Surgery. --- Family medicine. --- Radiology, Medical. --- Clinical radiology --- Radiology, Medical --- Radiology (Medicine) --- Medical physics --- Chemistry --- Drugs --- Materia medica --- Pharmacology --- Family practice (Medicine) --- General practice (Medicine) --- Physicians (General practice) --- Haematology --- Internal medicine --- Blood --- Dental surgery --- Odontology --- Surgery, Dental --- Oral medicine --- Teeth --- Surgery, Primitive --- Oral surgery --- Surgery, Oral --- Oral surgeons --- Radiological physics --- Physics --- Radiation
Listing 1 - 2 of 2 |
Sort by
|